[Update guide on pediatric multiple sclerosis].
Evidence indicates that early initiation of high-efficacy disease-modifying therapies is associated with improved long-term outcomes.
We have 2 of 11 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Evidence indicates that early initiation of high-efficacy disease-modifying therapies is associated with improved long-term outcomes.
Among pediatric patients with drug-resistant epilepsy, healthcare resource use substantially decreases after epilepsy surgery, especially when the patient does not require subsequent epilepsy surgeries.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.